Mission Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.13M | Buy |
16,879
+5,320
| +46% | +$701K | 0.03% | 296 |
|
|
2026
Q1 | $1.61M | Sell |
11,559
-1,130
| -9% | -$158K | 0.03% | 246 |
|
|
2025
Q4 | $1.56M | Sell |
12,689
-125
| -1% | -$15.2K | 0.03% | 254 |
|
|
2025
Q3 | $1.42M | Sell |
12,814
-64
| -0.5% | -$7.28K | 0.03% | 267 |
|
|
2025
Q2 | $1.43M | Sell |
12,878
-32
| -0.2% | -$3.41K | 0.03% | 254 |
|
|
2025
Q1 | $1.45M | Buy |
12,910
+2,285
| +22% | +$236K | 0.04% | 231 |
|
|
2024
Q4 | $981K | Sell |
10,625
-1,429
| -12% | -$129K | 0.02% | 291 |
|
|
2024
Q3 | $1.01M | Sell |
12,054
-413
| -3% | -$31.5K | 0.02% | 296 |
|
|
2024
Q2 | $855K | Buy |
12,467
+13
| +0.1% | +$868 | 0.02% | 312 |
|
|
2024
Q1 | $912K | Buy |
12,454
+368
| +3% | +$28.3K | 0.02% | 310 |
|
|
2023
Q4 | $979K | Buy |
12,086
+1,367
| +13% | +$106K | 0.03% | 239 |
|
|
2023
Q3 | $803K | Buy |
10,719
+340
| +3% | +$26.2K | 0.03% | 258 |
|
|
2023
Q2 | $800K | Sell |
10,379
-7,538
| -42% | -$601K | 0.03% | 263 |
|
|
2023
Q1 | $1.49M | Sell |
17,917
-4
| -0% | -$331 | 0.06% | 168 |
|
|
2022
Q4 | $1.54M | Sell |
17,921
-2,880
| -14% | -$228K | 0.07% | 146 |
|
|
2022
Q3 | $1.28M | Buy |
20,801
+1,113
| +6% | +$70.2K | 0.07% | 151 |
|
|
2022
Q2 | $1.22M | Sell |
19,688
-2,236
| -10% | -$138K | 0.06% | 163 |
|
|
2022
Q1 | $1.3M | Buy |
21,924
+8,302
| +61% | +$531K | 0.06% | 161 |
|
|
2021
Q4 | $989K | Sell |
13,622
-667
| -5% | -$45.9K | 0.04% | 197 |
|
|
2021
Q3 | $998K | Sell |
14,289
-2,040
| -12% | -$143K | 0.05% | 177 |
|
|
2021
Q2 | $1.12M | Sell |
16,329
-511
| -3% | -$34.1K | 0.06% | 158 |
|
|
2021
Q1 | $1.09M | Sell |
16,840
-2,093
| -11% | -$135K | 0.06% | 144 |
|
|
2020
Q4 | $1.1M | Buy |
18,933
+1,020
| +6% | +$61.5K | 0.07% | 135 |
|
|
2020
Q3 | $1.13M | Buy |
17,913
+148
| +0.8% | +$10.3K | 0.08% | 110 |
|
|
2020
Q2 | $1.37M | Buy |
17,765
+1,010
| +6% | +$77.4K | 0.12% | 91 |
|
|
2020
Q1 | $1.25M | Sell |
16,755
-28,723
| -63% | -$1.98M | 0.14% | 87 |
|
|
2019
Q4 | $2.96M | Sell |
45,478
-2,871
| -6% | -$187K | 0.28% | 52 |
|
|
2019
Q3 | $3.06M | Buy |
48,349
+30,707
| +174% | +$2.01M | 0.33% | 46 |
|
|
2019
Q2 | $1.19M | Sell |
17,642
-402
| -2% | -$26.4K | 0.13% | 85 |
|
|
2019
Q1 | $1.17M | Sell |
18,044
-87
| -0.5% | -$5.78K | 0.14% | 87 |
|
|
2018
Q4 | $1.13M | Sell |
18,131
-74
| -0.4% | -$5.17K | 0.15% | 79 |
|
|
2018
Q3 | $1.41M | Sell |
18,205
-277
| -1% | -$20.9K | 0.19% | 67 |
|
|
2018
Q2 | $1.31M | Buy |
18,482
+379
| +2% | +$26.8K | 0.19% | 67 |
|
|
2018
Q1 | $1.36M | Buy |
18,103
+15,318
| +550% | +$1.22M | 0.22% | 54 |
|
|
2017
Q4 | $200K | Sell |
2,785
-351
| -11% | -$26.7K | 0.03% | 215 |
|
|
2017
Q3 | $254K | Sell |
3,136
-788
| -20% | -$60.3K | 0.05% | 160 |
|
|
2017
Q2 | $278K | Buy |
3,924
+57
| +1% | +$3.79K | 0.05% | 135 |
|
|
2017
Q1 | $263K | Sell |
3,867
-758
| -16% | -$53.3K | 0.05% | 143 |
|
|
2016
Q4 | $331K | Buy |
4,625
+736
| +19% | +$54.7K | 0.07% | 120 |
|
|
2016
Q3 | $308K | Sell |
3,889
-30
| -0.8% | -$2.44K | 0.07% | 118 |
|
|
2016
Q2 | $327K | Sell |
3,919
-889
| -18% | -$78.9K | 0.09% | 106 |
|
|
2016
Q1 | $442K | Buy |
4,808
+1,183
| +33% | +$107K | 0.12% | 84 |
|
|
2015
Q4 | $367K | Buy |
3,625
+480
| +15% | +$49.9K | 0.1% | 86 |
|
|
2015
Q3 | $309K | Buy |
3,145
+91
| +3% | +$10.1K | 0.09% | 94 |
|
|
2015
Q2 | $300K | Buy |
+3,054
| New | +$334K | 0.1% | 97 |
|
Other funds holding GILD
Mission Wealth Management's GILD Position: Q2 2026 in Review
Mission Wealth Management increased its Gilead Sciences (GILD) stake by 46% in Q2 2026, buying an estimated $701K and bringing the position to 16,879 shares worth $2.13M. The position accounts for 0.03% of the portfolio, ranked #296.
Mission Wealth Management first reported a position in GILD in Q2 2015 and has held it in 45 quarters since. The position peaked at $3.06M in Q3 2019. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Mission Wealth Management held 16,879 shares of Gilead Sciences worth $2.13M as of Q2 2026.
- Mission Wealth Management bought 5,320 Gilead Sciences shares in Q2 2026, an estimated $701K.
- Gilead Sciences made up 0.03% of Mission Wealth Management's portfolio in Q2 2026, its #296 holding.
- Mission Wealth Management first reported a position in Gilead Sciences in Q2 2015 and has held it in 45 quarters since.
- Mission Wealth Management's Gilead Sciences position peaked at $3.06M in Q3 2019.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.